Hiroko Nomaguchi
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroko Nomaguchi.
Biochimica et Biophysica Acta | 1994
Hitoshi Hotokezaka; Hideaki Hayashida; Naoya Ohara; Hiroko Nomaguchi; Kazuhide Kobayashi; Takeshi Yamada
The homologue of groESL from Porphyromonas gingivalis was cloned and sequenced. Nucleotide sequencing suggested an operon containing two open reading frames (ORFs) homologous to groESL operon of Escherichia coli. The upstream ORF consisted of 267 bp corresponding to 89 amino acid residues. The downstream ORF consisted of 1635 bp corresponding to 545 amino acid residues.
Vaccine | 2000
Naoya Ohara; Masanori Matsuoka; Hiroko Nomaguchi; Mariko Naito; Takeshi Yamada
Immunization of mice with recombinant Mycobacterium bovis Bacillus Calmette-Guérin (rBCG) which over-produces a putative protective antigen candidate, the A component of antigen 85 complex (Ag85A), reduced the multiplication of Mycobacterium leprae in the foot pads of mice. The inhibition by this rBCG (rBCG/85A) was more evident than that with parental BCG. Repeated rBCG/85A immunization significantly could reduce M. leplae multiplication in mice. This is first report of rBCG to control mycobacterial infection in animal model. Therefore, rBCG technique may be useful for the development of a more effective mycobacteria vaccine.
Vaccine | 1999
Mariko Naito; Masanori Matsuoka; Naoya Ohara; Hiroko Nomaguchi; Takeshi Yamada
The proteins in culture filtrate derived from Bacillus Calmette-Guérin (BCG) were examined for protection against infection by Mycobacterium leprae. Immunization with the major secreted proteins, antigen 85 complex (Ag 85) A, B and C, induced effective protective immunity against multiplication of M. leprae in the foot pads of mice. The most effective protection was observed when mice were immunized with Ag 85A. A single immunization with Ag 85 could induce antigen-specific interferon gamma (IFNgamma) synthesis and more effective protection than live BCG vaccine. This study demonstrates that Ag 85 is an important immunoprotective molecule against leprosy infection.
Vaccine | 2001
Naoya Ohara; Masanori Matsuoka; Hiroko Nomaguchi; Mariko Naito; Takeshi Yamada
The components of Ag85 (Ag85A, Ag85B, and Ag85C) are putative protective antigen candidates against mycobacterial infection. A recombinant Mycobacterium bovis Bacillus Calmette-Guérin (rBCG) over-producing Ag85A, Ag85B, and MPB51 (rBCG/BA51) was constructed. rBCG/BA51 could secrete these antigens at levels more than five times higher than parental BCG. Immunization of C57BL/6 and BALB/c mice with this rBCG reduced the multiplication of Mycobacterium leprae in the foot pads of both strains of mice. The inhibition by rBCG/BA51 was more evident than that by parental BCG.
Vaccine | 1997
Masanori Matsuoka; Hiroko Nomaguchi; Hideharu Yukitake; Naoya Ohara; Sohkichi Matsumoto; Katsutoshi Mise; Takeshi Yamada
Immunization of mice with the ribosomal fraction from ruptured Mycobacterium bovis Bacillus Calmette-Guérin (BCG) and the culture filtrate reduced remarkably the multiplication of Mycobacterium leprae in the foot pads of mice. This is the first reported case of the protective activity against M. leprae multiplication in mice of the BCG ribosomal fraction and culture filtrate. The inhibition was more evident with the culture filtrate than with the ribosomal fraction. When the ribosomal proteins separated from ribosomal RNA were injected into mice, only slight inhibition was observed. Ribosomal RNA alone did not inhibit at all, in contrast to the conclusion reported by Youmans and Youmans.
Japanese journal of leprosy | 1989
Hiroko Nomaguchi; Yoshitane Dohi; Noriko Ohno; Tsuyoshi Fujiwara; Tonetaro Ito
Vijay Mehra et al. (1) reported that a unique glycolipid, PGL-1, of M. leprae was capable of inducing suppression of lymphocyte proliferation to Concanavalin A (Con A) in lymphocytes from lepromatous patients, but not in these from patients with tuberculoid leprosy, lepromin-positive contact or normal donors. However, cellular mechanisms of the suppression remain to be elucidated. In order to analyze cellular mechanisms underlying on the profound immune suppression in leprosy, it is desirable to develop mouse systems, even though M. leprae is nonpathogenic for mice. Here, we report the experimetally induced suppression of lymphocyte proliferation to con A or phytohemaggulutinin (PHA) by PGL-1 in mice and the preliminary analyses of the cellular mechanisms of the suppression.
Japanese journal of leprosy : official organ of the Japanese Leprosy Association | 2001
Hiroko Nomaguchi; Nilufar Jahan; Bhairab Chandra Mandal; Yasuko Yogi; Kunio Kawatsu; Yusuke Yoshizawa; Haruki Okamura; Masahiko Makino
We examined the effect of IL-12 and IL-18 on bactericidal activities of mouse peritoneal cell (PC) against Mycobacterium leprae (M. leprae). We demonstrated that IL-12 and IL-18 synergistically induced the NO-dependent bactericidal activity of PC by stimulating Natural Killer (NK) cells and T-cells through IFN-gamma production. IL-12 and IL-18 induced host cell death through NK-cells and T-cells. Therefore. IL-12 and IL-18 play an important role on direct killing of intracellular M. leprae and on indirect killing of them through inducing host cell death.
Fems Microbiology Letters | 2007
Yumi Maeda; Tetsu Mukai; Masanori Kai; Yasuo Fukutomi; Hiroko Nomaguchi; Chiyoji Abe; Kazuo Kobayashi; Seigo Kitada; Ryoji Maekura; Ikuya Yano; Norihisa Ishii; Toru Mori; Masahiko Makino
Japanese journal of leprosy | 1988
Hiroko Nomaguchi; Masanori Matsuoka; Yasuyo Miyata; Yuji Shigyo; Kenji Kohsaka; Subowo; Tonetaro Ito
Japanese journal of leprosy | 1987
Masanori Matsuoka; Hiroko Nomaguchi; Yasuyo Miyata; Tonetaro Ito